Prognostic Nomogram of Extranodal NK/T-cell Lymphoma
This study aims to evaluate prognostic factors for overall survival and explore risk progression-free survival in ENKTL, and establish a prognostic predictive nomogram for ENKTL patients.
Extranodal NK/T-cell Lymphoma
Overall survival, Time between the date of diagnosis and any kinds of death, 5 year
Progression-free survival, Time between the date of diagnosis and any kinds of death or relapse/progression, 5 year
This is a retrospective cohort study using anonymized information from patients with ENKTL. The following criteria are required: (1) Patients diagnosed with ENKTL between January 1, 2000 and August 31, 2020; (2) Patients older than 18 years. The pathology of initial diagnosis was reviewed by designated pathologists.